A Study to Demonstrate Bioequivalence Between 6 x 2 mg Tablets of Perampanel and a Single 12 mg Tablet of Perampanel in Healthy Subjects

Inclusion Criteria: * Healthy male or female subjects aged between 18-55 years. * BMI of 18-32 kg/m \^2. * Willing and able to provide written informed consent. Exclusion criteria: * Subjects taking prescribed or over the counter (OTC) medications in 2 weeks prior to screening. * Subjects on special diets or dietary aids known to modulate drug metabolizing enzymes. * Subjects who have taken inhibitor of CYP450 within 2 weeks of first dose. * Subjects who have received any experimental drug in the 12 weeks prior to study drug treatment. * Subjects with a history of alcohol abuse or who drink more than the recommended number of alcohol units per week. * Subjects who consume more than five caffeinated beverages per day. * Subjects who smoke more than 5 cigarettes per day. * Subjects with a history of drug abuse or who have a positive urine drug screening test. * Women who do not agree to use two methods of contraception.